ENGLISH
CBS2017
Previous Next
Home < 科学研究

搜索结果

数量：1763 条

排序

Refine search

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Clinical Trial | By Wanner C, Inzucchi SE, EMPA-REG OUTCOME Investigators.

BACKGROUND - Diabetes confers an increased risk of adverse cardiovascular and renal events. In the EMPA-REG OUTCOME trial, empagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of major adverse cardiovascular events in patients with type 2 diabetes at high risk for cardiovascular events. We wanted to determine the long-term renal effects of empagliflozin, an analysis that was a prespecified component of the...

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Clinical Trial | By Neal B, Perkovic V, CANVAS Program Collaborative Group.

BACKGROUND - Canagliflozin is a sodium-glucose cotransporter 2 inhibitor that reduces glycemia as well as blood pressure, body weight, and albuminuria in people with diabetes. We report the effects of treatment with canagliflozin on cardiovascular, renal, and safety outcomes. METHODS - The CANVAS Program integrated data from two trials involving a total of 10,142 participants with type 2 di...

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Clinical Trial | By Perkovic V, Jardine MJ, CREDENCE Trial Investigators.

BACKGROUND - Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes.   METHODS - In this double-blind, randomized trial, we assigned pat...

In-Hospital Coronary Revascularization Rates and Post-Discharge Mortality Risk in Non–ST-Segment Elevation Acute Coronary Syndrome

Original Research | By H Bueno, X Rossello, SJ Pocock et al.

BACKGROUND - The relationship between in-hospital coronary revascularization rate (CRR) and post-discharge mortality rates in survivors of non–ST-segment elevation acute coronary syndrome (NSTE-ACS) at a system level is unclear.   OBJECTIVES- The purpose of this study was to evaluate CRR and 2-year post-discharge mortality rate (2YMR) in NSTE-ACS.   METHOD...

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients

Review Article | By DKolte, GJ Vlahakes, IF Palacios et al.

BACKGROUND- Transcatheter aortic valve replacement (TAVR) has emerged as a safe and effective therapeutic option for patients with severe aortic stenosis (AS) who are at prohibitive, high, or intermediate risk for surgical aortic valve replacement (SAVR). However, in low-risk patients, SAVR remains the standard therapy in current clinical practice.   OBJECTIVES - This study sought to perfo...

Incidence and Outcomes of Surgical Bailout During TAVR : Insights From the STS/ACC TVT Registry

Original Research | By AM Pineda, JK Harrison, NS Kleiman et al.

OBJECTIVES - The aim of this study was to evaluate the incidence and outcomes of surgical bailout during transcatheter aortic valve replacement (TAVR).   BACKGROUND- The incidence and outcomes of unplanned conversion to open heart surgery, or “surgical bailout,” during TAVR are not well characterized.   METHODS- Data from the Society of Thoracic Surgeons/American College of C...

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

Original Research | By Nassif ME, Windsor S, DEFINE-HF Investigators.

Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary Look

Review Article | By McIlvennan CK, Morris MA, Guetterman TC et al.

Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research

Review Article | By Curry LA, Nembhard IM, Bradley EH.

From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes

Review Article | By Szummer K, Jernberg T, Wallentin L.

This focus seminar will take the reader through the history and pivotal trials that have formed the current state-of-the-art management for acute coronary syndromes. The identification of a ruptured plaque with thrombus formation and subsequent occlusion or downstream embolization in the coronary artery was the key to developing new and effective treatment strategies. The traditional wait-and-see approach with prolonged bedrest was repl...

By Article Type

Original Research 785
Review Article 294
Clinical Case Study 28
Clinical Trial 415
Perspective 9
Guideline 50

By Year

2019 6
2017 1
2016 1
2009 1
0 1

By Journal

N Engl J Med. 1
N Engl J Med. 2
JACC Cardiovasc Interv. 1
J Am Coll Cardiol. 1
J Am Coll Cardiol. 2
Circulation. 2
Circ Cardiovasc Qual Outcomes. 1

Limit By

Title
Content
|<<... 104 105 106 107 108 109 110 ...>>|
↑BACK TO TOP

左主干暨冠状动脉分叉病变峰会

南京市心血管医院丨南京市第一医院丨南京医科大学

长乐路68号丨210006丨中国 · 南京

Copyright ⓒ CBSMD Nanjing China. All rights reserved.

关于境内代表注册有疑问请联系彭红娟、徐海梅老师

+86 - 139 138 954 77 丨 +86 - 139 147 368 46 丨 cbsnj@cbsmd.org

关于境外代表注册有疑问请联系林玲老师

+86 - 139 518 845 96 丨 cbsnj@cbsmd.org

关于学术征集有疑问请联系赵莹莹女士

+86 138 154 085 17 丨 sub@cbsmd.org